Surmodics

SRDX · NASDAQ

Price unavailable right now.

No price history for this range.

Latest news

NewsDec 18, 10:04 AM ETVandana Singh
Medtech Integer Could Be More Valuable As A Private Company - Activist Investor Urges Strategic Review
Press releaseNov 17, 6:00 AM ETBusiness Wire
Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire Today
NewsNov 11, 12:17 PM ETAvi Kapoor
Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump
NewsNov 11, 12:09 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsNov 11, 10:08 AM ETAvi Kapoor
PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday
NewsNov 11, 9:40 AM ETAvi Kapoor
US Stocks Mixed; Sea Shares Gain After Q3 Results
Press releaseNov 10, 7:00 PM ETBusiness Wire
Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR
NewsNov 10, 7:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
Press releaseNov 4, 6:15 AM ETBusiness Wire
Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations
Press releaseNov 3, 6:15 AM ETBusiness Wire
Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3
Press releaseOct 29, 4:15 PM ETBusiness Wire
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform
Press releaseOct 27, 4:05 PM ETBusiness Wire
Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28
Press releaseAug 8, 7:00 AM ETBusiness Wire
Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance
NewsAug 8, 4:32 AM ET
Earnings Scheduled For August 8, 2025
NewsAug 7, 12:03 PM ET
What's Next: Surmodics's Earnings Preview
Press releaseAug 6, 4:05 PM ETBusiness Wire
Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8
NewsApr 30, 7:01 AM ET
Surmodics Q2 Adj. EPS $(0.13) Misses $(0.11) Estimate, Sales $28.09M Miss $32.23M Estimate
Press releaseApr 30, 7:00 AM ETBusiness Wire
Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance
NewsApr 30, 4:32 AM ET
Earnings Scheduled For April 30, 2025
NewsApr 29, 3:03 PM ET
A Look at Surmodics's Upcoming Earnings Report
Press releaseApr 28, 6:00 PM ETBusiness Wire
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
Press releaseApr 22, 7:00 AM ETBusiness Wire
Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon
NewsApr 4, 3:07 PM ETAnthony Noto
Deal Dispatch: US M&A Is Quiet, But Abroad? Volume Is Spiking
Press releaseApr 3, 7:00 AM ETBusiness Wire
Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries
NewsMar 7, 2:47 PM ETAnthony Noto
Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private
NewsMar 7, 9:56 AM ETNabaparna Bhattacharya
Why Surmodics Stock Is Falling On Friday
NewsMar 7, 2:52 AM ET
Surmodics Vows to Fight FTC Lawsuit Blocking $627M Acquisition by GTCR
Press releaseMar 6, 9:00 PM ETBusiness Wire
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR
NewsFeb 6, 7:01 AM ETAvi Kapoor
Top 3 Health Care Stocks You'll Regret Missing This Month
Press releaseFeb 3, 7:00 AM ETBusiness Wire
Surmodics Announces Successful Early Clinical Use of Pounce™ XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral Arteries
Press releaseJan 30, 7:00 AM ETBusiness Wire
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results
Press releaseNov 6, 7:00 AM ETBusiness Wire
Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Press releaseOct 30, 2:30 PM ETBusiness Wire
Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System
Press releaseOct 1, 7:00 AM ETBusiness Wire
Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter
Press releaseJul 31, 7:00 AM ETBusiness Wire
Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Medtech Integer Could Be More Valuable As A Private Company - Activist Investor Urges Strategic Review

Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire Today

Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump

12 Health Care Stocks Moving In Tuesday's Intraday Session

PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday

US Stocks Mixed; Sea Shares Gain After Q3 Results

Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR

12 Health Care Stocks Moving In Monday's Pre-Market Session

Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations

Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3

Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform

Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28

Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance

Earnings Scheduled For August 8, 2025

What's Next: Surmodics's Earnings Preview

Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8

Surmodics Q2 Adj. EPS $(0.13) Misses $(0.11) Estimate, Sales $28.09M Miss $32.23M Estimate

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance

Earnings Scheduled For April 30, 2025

A Look at Surmodics's Upcoming Earnings Report

Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30

Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon

Deal Dispatch: US M&A Is Quiet, But Abroad? Volume Is Spiking

Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries

Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private

Why Surmodics Stock Is Falling On Friday

Surmodics Vows to Fight FTC Lawsuit Blocking $627M Acquisition by GTCR

Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR

Top 3 Health Care Stocks You'll Regret Missing This Month

Surmodics Announces Successful Early Clinical Use of Pounce™ XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral Arteries

Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results

Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System

Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter

Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results